GlassScriptPhysician profile
Ahmed M Hasan
NPI 1477548865
$6,221.16
in general payments reported to CMS, 2019-2025
32 companies · $1,234 in 2025
The $1,234 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $512 · 2020: $679 · 2021: $548 · 2022: $812 · 2023: $1,119 · 2024: $1,318 · 2025: $1,234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,640 · Education: $30.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,640.28 |
| Education | $30.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,554.65 | 2019-2025 | |
| Janssen Biotech, INC. | $928.43 | 2019-2025 | Stelara, Tremfya, Simponi |
| Takeda Pharmaceuticals U.S.A., INC. | $650.67 | 2019-2025 | Entyvio, Eohilia, Gattex |
| Celgene Corporation | $359.89 | 2022-2024 | Zeposia |
| Pfizer INC. | $322.59 | 2019-2025 | |
| Madrigal Pharmaceuticals | $294.85 | 2024-2025 | Rezdiffra, Resmetirom |
| Phathom Pharmaceuticals, INC. | $287.26 | 2024-2025 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $279.03 | 2019-2023 | Xifaxan |
| Gilead Sciences, INC. | $276.20 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $195.08 | 2021-2023 | Zeposia |
| Intercept Pharmaceuticals, INC. | $181.23 | 2021-2025 | Ocaliva |
| Merck Sharp & Dohme LLC | $98.03 | 2019-2024 | Zerbaxa, Dificid |
| Lilly USA, LLC | $85.57 | 2023-2025 | Omvoh |
| Astrazeneca Pharmaceuticals LP | $79.92 | 2024 | Airsupra |
| Shionogi INC | $66.27 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $52.57 | 2022-2024 | Dupixent |
| Steris Corporation | $52.53 | 2020 | |
| Echosens North America, INC. | $49.13 | 2023-2025 | Fibroscan, Fibroscan |
| Biofire Diagnostics, LLC | $48.38 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $43.94 | 2024 | Bylvay, Iqirvo |
| Qol Medical, LLC | $39.24 | 2022-2023 | Sucraid |
| Ironwood Pharmaceuticals, INC | $37.33 | 2022-2024 | |
| Genzyme Corporation | $35.16 | 2024 | |
| Ferring Pharmaceuticals INC. | $35.05 | 2023-2025 | Rebyota |
| Exact Sciences Corporation | $34.40 | 2024 | Cologuard Collection Kit |
| Axonics, INC. | $26.15 | 2023 | Axonics |
| Allergan, INC. | $22.46 | 2019-2020 | |
| Braintree Laboratories, INC. | $22.08 | 2019 | |
| Ardelyx, INC. | $19.44 | 2023 | Ibsrela |
| Medtronic, INC. | $17.58 | 2023 | Gi Genius |
| Capsovision, INC. | $13.13 | 2025 | Capsocam Plus |
| Mauna Kea Technologies, INC. | $12.92 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Hasan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.